Clinical Trial Update: Hypercoagulable Parameters as Predictors of Thrombotic Events and Prognosis in Patients With Advanced Non-Small Cell Lung Carcinoma

View source ↗

Summary

A clinical trial update examining whether hypercoagulable parameters can predict thrombotic events and prognosis in patients with advanced non-small cell lung c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Carcinoma
• Venous Thromboembolism

Snippet

Sponsor: Rambam Health Care Campus | Conditions: Non-Small Cell Lung Carcinoma, Venous Thromboembolism | Status: UNKNOWN